Learn More
MedChemExpress LSKL, Inhibitor of Thrombospondin (TSP-1)
Description
LSKL, Inhibitor of Thrombospondin (TSP-1) inhibits the binding of TSP-1 to LAP and alleviates renal interstitial fibrosis and hepatic fibrosis. LSKL, Inhibitor of Thrombospondin (TSP-1) suppresses subarachnoid fibrosis via inhibition of TSP-1-mediated TGF-β1 activity, prevents the development of chronic hydrocephalus and improves long-term neurocognitive defects following subarachnoid hemorrhage (SAH). LSKL, Inhibitor of Thrombospondin (TSP-1) can readily crosse the blood-brain barrier.
Specifications
Specifications
| CAS | 283609-79-0 |
| Content And Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| For Use With (Application) | Cancer-Kinase/protease |
| Molecular Weight (g/mol) | 458.6 g/mol |
| Product Type | Peptides |
| Quantity | 25 mg |
| Shipping Condition | Room temperature |
| Solubility | DMSO : ≥ 100 mg/mL (218.05 mM) ∣H2O : 50 mg/mL (109.03 mM∣Need ultrasonic) |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.